✦ LIBER ✦

The Immunophilin Ligands Cyclosporin A and FK506 Suppress Prostate Cancer Cell Growth by Androgen Receptor-Dependent and -Independent Mechanisms

✍ Scribed by Periyasamy, Sumudra; Warrier, Manya; Tillekeratne, Manoranjani P. M.; Shou, Weinian; Sanchez, Edwin R.

Book ID: 118049948
Publisher: Endocrine Society
Year: 2007
Tongue: English
Weight: 370 KB
Volume: 148
Category: Article
ISSN: 0013-7227
DOI: 10.1210/en.2007-0145

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FKBP51 and Cyp40 are positive regulators

FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A

✍ Periyasamy, S; Hinds, T; Shemshedini, L; Shou, W; Sanchez, E R 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 772 KB

Re: Ligand-Dependent Corepressor Acts as

Re: Ligand-Dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and is Functionally Inactivated by the Src Protein Kinase

✍ Atala, Anthony 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 85 KB

Constitutive activation of the androgen

Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen-independent growth in prostate cancer

✍ Jocelyn Céraline; Marion D. Cruchant; Eva Erdmann; Philippe Erbs; Jean-Emmanuel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 278 KB 👁 2 views

## Abstract Androgen receptor (AR) mutations that modify both the ligand binding and the transactivation capacities of the AR represent one of the mechanisms involved in the transition of prostate cancer (PCa) from androgen‐dependent to androgen‐independent growth. We use a yeast‐based functional a

Insulin-like growth factor-binding prote

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

✍ Uzoh, C C; Holly, J M P; Biernacka, K M; Persad, R A; Bahl, A; Gillatt, D; Perks 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB

880 Prostate cancer cell proliferation i

880 Prostate cancer cell proliferation is strongly reduced by combination treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (‘Iressa’) and the anti -androgen bicalutamide (‘casodex’)

✍ M. Bologna; A. Angelucci; C. Festuccia; G.L. Gravina; P. Muzi; C. Vicentini 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

GP2-2: The deubiquitinating enzyme, USP9

GP2-2: The deubiquitinating enzyme, USP9X positively regulates insulin-like growth factor (IGF)-dependent cell growth by inhibition of degradation of IGF-I receptor (IGF-IR) and insulin receptor substrate (IRS)-2 in prostate cancer cells

✍ Furuta, H.; Yoshihara, H.; Fukushima, T.; Saeki, Y.S.; Ito, A.; Worrall, C.; Gir 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 448 KB